HIV: Page 2

G Medical Innovations to provide numerous at-home testing kits to consumers
By LabPulse.com staff writers
The tests include screening for monkeypox, colon cancer, thyroid issues, and sexually transmitted diseases (STDs) such as HIV and syphilis, as well as tests for many other health issues, the company said.
October 7, 2022
Fingerprick Blood
Week in Review: Roche’s new MDx system, HIV world market, cervical cancer testing disparities, and more
By Leo O'Connor
Dear LabPulse.com member,
August 24, 2022
Kalorama Information values 2021 HIV testing market at $2.597B
By Leo O'Connor
Of the different types of tests, HIV immunoassays are expected to see a compound annual growth rate (CAGR) of 3.2% from 2021 through 2026, said the report, which is published by LabPulse.com's sister brand Kalorama Information.
August 18, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Thermo Fisher releases RUO assay for HIV variants
By LabPulse.com staff writers
Specifically, the assay analyses HIV RNA extracted from ethylenediaminetetraacetic acid (EDTA) plasma or dried blood spots to measure genomic mutations in the protease, reverse transcriptase, and integrase regions of the pol gene.
August 7, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Gilead offers $24M in grants to address HIV disparities
By LabPulse.com staff writers
The grants will support 116 organizations in 41 countries and aim to improve access to quality healthcare and advance medical education in targeted communities. Organizations granting Zeroing In program funds will specifically prioritize populations most affected by the HIV epidemic, with a focus on collaboration with local communities, the company said in a release.
March 31, 2022
2021 01 08 23 53 2466 Business Hands Cooperation 400
Severe COVID-19 risk linked to lower HIV risk
By Leah Sherwood
The variant in question, which is associated with severe COVID-19, is located on chromosome 3 in a region that encodes for chemokine receptors. Individuals who carry the factor have decreased levels of the chemokine receptors CCR3, CCR5, and CXCR6, which was the clue to the link with HIV infection, since low values of these three receptors are associated with a lower prevalence of HIV infection, according to the paper's author, Hugo Zeber, PhD, of the Max Planck Institute for Evolutionary Anthropology.
February 24, 2022
2022 02 22 23 25 2921 Covid Dna Sequencing 400
Fla. university awarded $1.3M from NIH for HIV test
By LabPulse.com staff writers
With the grant, FAU researchers hope to develop an affordable, disposable self-testing HIV-1 chip that can selectively detect HIV from whole blood samples. The researchers are aiming for an automated test that requires no refrigeration and can produce results within 40 minutes. They also said it will be sensitive enough to detect HIV during acute infection, treatment, and viral rebound, according to a press release issued by the university.
January 17, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Hologic adds SARS-CoV-2 test to global testing project
By LabPulse.com staff writers
Hologic launched GAI at the 2018 International AIDS Conference as an initiative to offer an all-inclusive pricing structure with no upfront cost or capital expenditure. In addition to the SARS-CoV-2 assay, the company offers other tests in the initiative, including tests for HIV-1, hepatitis B and C, and HPV.
January 4, 2022
2021 10 08 23 57 9144 Earth Hands Globe World 400
Roche launches test on new Cobas 5800 lab system
By LabPulse.com staff writers
The following Cobas tests can run on the new compact system:
December 14, 2021
2020 04 14 17 10 6379 Test Tubes Rd Lab 400
How pathologists act as 'firefighters' during COVID-19
By Rebekah Moan
Especially in the early stages of the pandemic, there were numerous unknowns about how to proceed with autopsies because COVID-19 was an unknown disease. What type of infectious disease was it? Was it like tuberculosis, HIV, hepatitis C, or mad cow disease?
October 3, 2021
2021 04 27 15 25 5437 Pathology Digital Workstation Microscope 400
FDA OK's new claim for Hologic's HIV assay
By LabPulse.com staff writers
The Aptima HIV-1 Quant Dx is now the first dual-claim assay for both diagnosis and viral load monitoring in the U.S., Hologic said. First approved in late 2016 for viral load monitoring, the assay is a molecular diagnostic test that runs on the automated, sample-to-result Panther system. It uses a dual target approach against highly conserved regions in the HIV genome designed to deliver results across HIV-1 groups and subtypes, Hologic said.
November 19, 2020
2019 02 13 19 24 5396 Fda Logo V2 400
Truvian's COVID-19 antibody test cleared by FDA
By LabPulse.com staff writers
The antibody test offers 98.4% sensitivity and 98.9% specificity, and has been tested and validated by healthcare professionals and scientists at the University of California, San Diego (UCSD) and the University of Chicago, according to the company. Furthermore, company evaluation suggests no cross-reactivity with HIV, influenza A and B, and several coronavirus strains, Truvian said.
July 29, 2020
2020 06 17 20 35 0417 Covid 19 Antibody 400
Previous Page
Page 2 of 4
Next Page